PABESORAG TAB. 150 MG./12.5 MG. CAJA C/28 (IRBESARTAN-HIDROCLOTIAZIDA) PATENTE FORMA FARMACÉUTICA: 3 TABLETAS

Description

FORMA FARMACÉUTICA: 3 TABLETAS

PRESENTACIÓN: 1 CAJA

PRINCIPIO ACTIVO: LEVODROPROPICINA

PRINCIPIO ACTIVO: SITAGLIPTINA - METFORMINA

DOSIS: 50/1000 MG

PABESORAG TAB. 150 MG./12.5 MG. CAJA C/28 (IRBESARTAN-HIDROCLOTIAZIDA) PATENTE FORMA FARMACÉUTICA: 3 TABLETAS

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy